You are here
VM DISCOVERY, INC.
UEI: N/A
# of Employees: 0
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Preclinical Development of Selective PKC_epsilon Inhibitors to Treat Alcoholism
Amount: $972,772.00DESCRIPTION (provided by applicant): Alcohol abuse and alcoholism (alcohol use disorders) are significant public health issues and represent one of the largest public health problems. In the United St ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
Not Available
Amount: $207,803.00Breast cancer is a devastating affliction in Western Society. It is of high interest to quantify the expression of HER2/neu (a growth factor receptor), the estrogen receptor (ER), and the progesteron ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
DEVELOPMENT OF ANTI-CANCER AGENTS.
Amount: $198,224.00The overall objective of this proposal is to preclinically develop VMD-1201 or a lead analog compound of a preferentially peripheral-acting PKC epsilon inhibitor as an oral targeted anticancer drug fo ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
Preclinical Development of Selective PKC_epsilon Inhibitors to Treat Alcoholism
Amount: $498,258.00DESCRIPTION (provided by applicant): Alcoholism and alcohol abuse are the most common forms of drug abuse and effect about 8% of the U.S. population at a cost of approximately $184 billion a year. Cur ...
SBIRPhase II2007Department of Health and Human Services National Institutes of Health -
Multi-Property Design Selective PKC_epsilon Inhibitors
Amount: $98,153.00DESCRIPTION (provided by applicant): Protein kinase C inhibitors have been rendered as attractive targets for therapeutic agents. Recent studies have been shown that PKC epsilon isozyme is a valid new ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health